Insulin Aspart

Brand name: Novolog Flexpen

Rank #21 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$831.6M

Total Cost

Share:

958,823

Total Claims

$831.6M

Total Cost

29,922

Prescribers

$867

Cost per Claim

161,779

Beneficiaries

1,529,552

30-Day Fills

$28K

Avg Cost/Provider

32

Avg Claims/Provider

Share of Medicare Part D Spending

0.30%

of total Medicare Part D spending

$831.6M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $831.6M total

🔎 Data Overview

📊

Ranked #21 out of 500 drugs tracked by total cost. Insulin Aspart represents a significant portion of Medicare drug spending.

👤

Average cost of $5,140 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Insulin Aspart

#ProviderSpecialtyLocationClaimsCost
1Michael VavrikEndocrinologyCarrollton, GA428$831K
2Misty GillilandNurse PractitionerChattanooga, TN454$786K
3Mohammad IjazEndocrinologyZanesville, OH434$656K
4Anthony GiglioPhysician AssistantSpringfield, MO600$650K
5Stacy CongdonNurse PractitionerJohnson City, NY305$633K
6Charla YassineCertified Clinical Nurse SpecialistWichita, KS466$629K
7Mark JohnsonEndocrinologyMason City, IA627$621K
8Francis ArceInternal MedicineOswego, NY287$608K
9Jaweed AkhterEndocrinologyBeaumont, TX419$604K
10Bobby JohnsonEndocrinologyHuntsville, AL334$602K
11Dennis Roy FerrerEndocrinologyShenandoah, TX502$589K
12Michael LinEndocrinologySan Gabriel, CA518$583K
13Michael ValituttoInternal MedicineKalamazoo, MI354$576K
14Jamie MillerNurse PractitionerMadisonville, KY433$567K
15Lisa Gowey-FischerNurse PractitionerMarshfield, WI454$565K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
18Ibrutinib (Imbruvica)$875.8M56,368
19Ustekinumab (Stelara)$852.3M31,974
20Paliperidone Palmitate (Invega Sustenna)$832.3M252,388
21Insulin Aspart (Novolog Flexpen)$831.6M958,823
22Budesonide/Formoterol Fumarate (Symbicort)$759.4M1,452,561
23Palbociclib (Ibrance)$755.1M48,329
24Nintedanib Esylate (Ofev)$703.7M53,928

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology